Depression Treatment in Scottsdale, AZ
Depression is one of the most serious and pervasive medical conditions in the United States, affecting people across all ages, backgrounds, and walks of life. At The Schulte Institute in Scottsdale, AZ, we specialize in evidence-based depression care — including advanced interventional options for patients who have not found adequate relief through traditional treatments. If you or someone you love is struggling with depression in Scottsdale, our team is here to help you find a meaningful path forward.
Request an AppointmentUnderstanding Depression: A Serious Medical Condition
Depression is far more than persistent sadness — it is a complex neurological and medical condition characterized by significant disruptions in mood, thought patterns, motivation, behavior, and physical health. Common symptoms include a persistent depressed mood, loss of interest in previously enjoyed activities, changes in appetite or weight, disrupted sleep patterns, fatigue, difficulty concentrating, feelings of worthlessness, and in severe cases, thoughts of self-harm or suicide. These symptoms can severely impair daily functioning and quality of life when left untreated.
The economic burden of depression in the United States now exceeds $300 billion annually, encompassing both direct treatment costs and indirect costs such as lost productivity. Depression is on track to become one of the leading causes of disability worldwide in the coming years. Each year, over 30,000 people in the U.S. die by suicide — with 60% of those individuals suffering from depression. Women are nearly twice as likely as men to experience a depressive episode, though depression in men is frequently underreported and undertreated. Approximately two-thirds of people who experience one depressive episode will experience at least one more in their lifetime, underscoring the importance of finding an effective, sustainable treatment approach.
The Biology of Depression: Why the Brain Matters
Research consistently points to decreased activity in the brain’s neural networks that regulate emotion, motivation, and reward as a core neurobiological feature of depression. When the synaptic connections in mood-regulating brain regions — particularly the prefrontal cortex — weaken or become less active, the brain loses its capacity to sustain emotional balance, and depressive symptoms emerge. This is why depression is not simply a matter of attitude or willpower — it is rooted in measurable neurological changes.
Antidepressant medications work by raising levels of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain, which can help reactivate these neural circuits or promote the formation of new synaptic connections. For many patients, antidepressants provide meaningful relief. However, because these medications are distributed systemically through the bloodstream, they also affect the rest of the body — which is why side effects such as weight gain, sexual dysfunction, nausea, dry mouth, sleepiness, and GI distress are so prevalent. More than 4 million people in the U.S. either fail to achieve sufficient benefit from antidepressants or are unable to tolerate their side effects — making access to alternative treatments critically important.
Treatment-Resistant Depression: When Medication Is Not Enough
When depression does not respond adequately to antidepressant medications — even after multiple trials at appropriate doses and durations — it is often referred to as treatment-resistant depression (TRD). While TRD is not a formal DSM diagnostic term, it represents a very real clinical challenge that affects a significant portion of patients with MDD. Research from the landmark STAR*D study found that with each subsequent antidepressant trial, the probability of achieving remission decreases substantially, and the likelihood of abandoning treatment due to intolerable side effects increases.
For patients in Scottsdale dealing with treatment-resistant depression, The Schulte Institute offers two of the most clinically advanced alternative treatments available: NeuroStar Advanced TMS Therapy — a non-invasive, FDA-cleared treatment that uses focused magnetic pulses to directly reactivate the underactive brain circuits responsible for depression — and Spravato (esketamine) nasal spray — an FDA-approved medication that targets the NMDA receptor in the brain to produce rapid antidepressant effects, often within hours to days. Both treatments are available at our Scottsdale practice and may be used individually or in combination depending on your clinical needs. To learn more about candidacy for TMS therapy, visit our Candidates page. For a deeper look at how TMS works, visit our How It Works page.
Frequently Asked Questions About Depression Treatment in Scottsdale
What is depression and how is it different from normal sadness?
Depression is a serious medical condition characterized by persistent disruptions in mood, motivation, cognitive function, sleep, appetite, and physical energy that interfere significantly with daily life. Unlike normal sadness — which is typically tied to a specific event and resolves over time — clinical depression persists for weeks or months, is not necessarily tied to external circumstances, and is rooted in measurable neurological and neurochemical changes in the brain. Effective treatment requires a clinical diagnosis and a structured treatment plan.
What causes depression?
Depression is linked to decreased activity in the brain’s mood-regulating neural networks — particularly the prefrontal cortex — as well as imbalances in neurotransmitters such as serotonin, norepinephrine, and dopamine. Contributing factors can include genetics, life experiences, chronic stress, hormonal changes, other medical conditions, and medication side effects. Because depression has multiple potential causes and presentations, treatment must be individualized. At The Schulte Institute, Dr. Schulte and Dr. Koreny conduct comprehensive evaluations to understand each patient’s unique clinical picture before recommending a treatment approach.
When should someone seek professional help for depression?
If depressive symptoms — such as persistent low mood, loss of interest in activities, significant changes in sleep or appetite, fatigue, difficulty concentrating, or feelings of hopelessness — have lasted two weeks or longer and are interfering with your ability to function at work, in relationships, or in daily life, it is time to seek professional help. If you are experiencing thoughts of self-harm or suicide, seek help immediately. The Schulte Institute is available at (480) 941-9004 during office hours, and crisis resources are available 24/7 through the 988 Suicide and Crisis Lifeline.
What treatment options does The Schulte Institute offer for depression?
The Schulte Institute offers a comprehensive range of depression treatments, including NeuroStar Advanced TMS Therapy — FDA-cleared for MDD, anxious depression, and treatment-resistant depression — and Spravato (esketamine) nasal spray, FDA-approved for treatment-resistant depression and MDD with acute suicidal ideation. We also offer off-label TMS for conditions including bipolar depression. Learn more on our TMS page, our Spravato page, and our TMS Off-Label page.
What is treatment-resistant depression and what are my options?
Treatment-resistant depression (TRD) refers to MDD that has not responded adequately to at least two antidepressant medications at appropriate doses and durations. For patients in Scottsdale with TRD, The Schulte Institute offers NeuroStar TMS therapy — which directly stimulates the underactive brain circuits responsible for depression — and Spravato (esketamine) nasal spray, which targets the NMDA receptor to produce rapid antidepressant effects. Both treatments are available at our practice and may be used individually or in combination.
How do NeuroStar TMS and Spravato differ as depression treatments?
NeuroStar TMS is a non-drug, non-invasive treatment that uses focused magnetic pulses to directly stimulate underactive mood-regulating brain regions over a course of 36 sessions. It carries no systemic side effects and requires no sedation or recovery time. Spravato is an FDA-approved nasal spray that targets the brain’s NMDA receptors and can produce rapid antidepressant effects within hours to days. It is administered in-office under clinical supervision and used alongside an oral antidepressant. The right choice — or combination — depends on your individual clinical profile, which our providers evaluate during your consultation.
How do I schedule a depression consultation at The Schulte Institute in Scottsdale?
Call (480) 941-9004 or submit a request through our appointments page to schedule a consultation at The Schulte Institute in Scottsdale. During your appointment, Dr. Schulte or Dr. Koreny will conduct a thorough psychiatric evaluation, review your treatment history, and develop a personalized treatment plan that addresses the full scope of your depression symptoms and goals.
